Literature DB >> 6993374

Tumour-related changes in natural killer cell activity in melanoma patients. Influence of stage of disease, tumour thickness and age of patients.

P Hersey, A Edwards, W H McCarthy.   

Abstract

The influence of tumour growth on the natural killer (NK) activity of melanoma patients was examined by analysis of NK activity in 51Cr release assays before and at intervals after surgical removal of localized melanoma. In patients with Stage I and II melanoma, removal of the tumour was associated with changes in the level of NK activity which were not detected in patients who had surgery for skin graft after previous removal of the primary melanoma. The changes in NK activity after removal of melanoma were however different in patients with Stage I compared to Stage II melanoma. In the former, NK activity which appeared specifically directed toward melanoma cells was maximal 2-4 weeks after removal of the tumour and then decreased to normal levels. The NK activity after surgery was directly related to the thickness of the tumour. In patients with Stage II melanoma, NK activity did not increase but fell to low levels after removal of the tumour. The level of NK activity in these patients was not related to the thickness of their primary melanoma. In patients with Stage I and II melanoma the NK activity against melanoma cells showed a significant increase with age. The reason for the different sequence of changes in NK activity after removal of melanoma in the two patient groups is unknown. It is suggested however that the differences observed in patients with Stage II melanoma may reflect differences in the tumour or host response which contributed to the spread of the tumour to regional lymph nodes in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6993374     DOI: 10.1002/ijc.2910250204

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Peripheral blood lymphocytes from thermal injury patients are defective in their ability to generate lymphokine-activated killer (LAK) cell activity.

Authors:  G R Klimpel; D H Herndon; M D Stein
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

2.  Deficient natural killer cell activity in a patient with Fanconi's anaemia and squamous cell carcinoma. Association with defect in interferon release.

Authors:  P Hersey; A Edwards; R Lewis; A Kemp; J McInnes
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

3.  Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma.

Authors:  C Müller; H Pehamberger; M Binder; C C Zielinski
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.

Authors:  M Oka; H Mitsunaga; S Hazama; S Yoshino; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

5.  Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.

Authors:  W L Sibbitt; P M Mathews; A D Bankhurst
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

6.  Natural killer activity of peripheral blood lymphocytes and its relation to histopathological factors of lung cancer.

Authors:  A Terazawa; N Tanaka; N Senou; F Inoue; H Matsuura; A Gouchi; S Fuchimoto; H Mimura; K Orita
Journal:  Jpn J Surg       Date:  1987-07

7.  Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus.

Authors:  J A Byrne; M Soloski; J A Holowczak
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.

Authors:  P Hersey; A Edwards; G D'Alessandro; M MacDonald
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Defective NK cell activity following thermal injury.

Authors:  G R Klimpel; D N Herndon; M Fons; T Albrecht; M T Asuncion; R Chin; M D Stein
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

Review 10.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.